Analysen von Richard Vosser

21.04.20 Sartorius vz. overweight JP Morgan Chase & Co.
17.04.20 Roche overweight JP Morgan Chase & Co.
16.04.20 Roche overweight JP Morgan Chase & Co.
14.04.20 Novo Nordisk overweight JP Morgan Chase & Co.
09.04.20 Sanofi overweight JP Morgan Chase & Co.
01.04.20 Roche overweight JP Morgan Chase & Co.
30.03.20 Roche overweight JP Morgan Chase & Co.
17.03.20 Novo Nordisk overweight JP Morgan Chase & Co.
09.03.20 Roche overweight JP Morgan Chase & Co.
09.03.20 AstraZeneca overweight JP Morgan Chase & Co.
25.02.20 Sanofi overweight JP Morgan Chase & Co.
11.02.20 Sanofi overweight JP Morgan Chase & Co.
06.02.20 Roche overweight JP Morgan Chase & Co.
06.02.20 Sanofi overweight JP Morgan Chase & Co.
06.02.20 Novo Nordisk overweight JP Morgan Chase & Co.
03.02.20 Roche overweight JP Morgan Chase & Co.
30.01.20 Roche overweight JP Morgan Chase & Co.
29.01.20 Novo Nordisk overweight JP Morgan Chase & Co.
27.01.20 Novo Nordisk overweight JP Morgan Chase & Co.
27.01.20 Sanofi overweight JP Morgan Chase & Co.
23.01.20 Roche overweight JP Morgan Chase & Co.
07.01.20 Roche overweight JP Morgan Chase & Co.
06.01.20 MorphoSys overweight JP Morgan Chase & Co.
06.01.20 Sartorius vz. overweight JP Morgan Chase & Co.
06.01.20 AstraZeneca overweight JP Morgan Chase & Co.
06.01.20 Sanofi overweight JP Morgan Chase & Co.
06.01.20 Novo Nordisk overweight JP Morgan Chase & Co.
06.01.20 Roche overweight JP Morgan Chase & Co.
02.01.20 Roche overweight JP Morgan Chase & Co.
25.11.19 Roche overweight JP Morgan Chase & Co.
21.11.19 Novo Nordisk overweight JP Morgan Chase & Co.
04.11.19 Novo Nordisk overweight JP Morgan Chase & Co.
01.11.19 Novo Nordisk overweight JP Morgan Chase & Co.
21.10.19 Roche overweight JP Morgan Chase & Co.
17.10.19 Roche overweight JP Morgan Chase & Co.
16.10.19 Roche overweight JP Morgan Chase & Co.
11.10.19 Roche overweight JP Morgan Chase & Co.
02.10.19 Roche overweight JP Morgan Chase & Co.
30.09.19 Roche overweight JP Morgan Chase & Co.
23.09.19 Novo Nordisk overweight JP Morgan Chase & Co.
20.09.19 Novo Nordisk overweight JP Morgan Chase & Co.
18.09.19 Novo Nordisk overweight JP Morgan Chase & Co.
17.09.19 Roche overweight JP Morgan Chase & Co.
13.09.19 Roche overweight JP Morgan Chase & Co.
12.09.19 Novo Nordisk overweight JP Morgan Chase & Co.
05.09.19 Novo Nordisk overweight JP Morgan Chase & Co.
05.09.19 Roche overweight JP Morgan Chase & Co.
28.08.19 Roche overweight JP Morgan Chase & Co.
28.08.19 Novo Nordisk overweight JP Morgan Chase & Co.
28.08.19 AstraZeneca overweight JP Morgan Chase & Co.